PAR 2.17% 23.5¢ paradigm biopharmaceuticals limited..

On the road to growth!, page-17

  1. 292 Posts.
    lightbulb Created with Sketch. 110
    Yes I agree completely - to my mind the potential value here is for PPS to become a mass-market default treatment for OA, and possibly a range of other indications. For this to happen I think the strategy would probably be to get it out there to as many people as possible, as soon as possible, and not be too ambitious on the pricing.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.5¢
Change
0.005(2.17%)
Mkt cap ! $82.20M
Open High Low Value Volume
23.5¢ 23.5¢ 23.0¢ $85.35K 365.1K

Buyers (Bids)

No. Vol. Price($)
10 280011 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 44703 3
View Market Depth
Last trade - 16.10pm 06/09/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.